Biocon to acquire Viatris’ biosimilars assets in a deal worth US$3.3 billion by Editor | Feb 28, 2022 | Hospitals, LATEST NEWS, WORLD NEWS | 0 INDIA – Biocon Biologics, a Biocon subsidiary, has announced that it will purchase Viatris’... Read More